The Community Guide

- gsearch

Search Results

Narrow Results:

2020 2
2019 3
2018 4
2015 1
2011 1

Journal Article 11

Adjuvant 1
CAST/EiJ mice 1
Gonadotrophin-releasing hormone (GnRH) 1
Immune response 1
Immunocontraceptive vaccine 1
Laser microporation 1
Orthopoxvirus 1
Particulate vaccine 1
Poloxamer Gels 1
Rabies 1
Rabies vaccines 1
Skin vaccination 1
Smallpox 1
Variola virus 1

1 - 11 of 11 Results

Refine Results

Refine Results:

Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues

CITE Title : Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues Personal Author(s) : Reed, Matthew;Stuchlik, Olga;Carson, William C.;Orciari, Lillian;Yager, Pamela A.;Olson, Victoria;Li, Yu;Wu, Xianfu;Pohl, Jan;Satheshkumar, Panayampalli Subbian; Published Date : December 14 2018 Source : PLoS Negl Trop Dis. 12(12) URL : https://stacks.cdc.gov/view/cdc/77375 Reed, Matthew et al. (2018). Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues. 12(12). Reed, Matthew et al. "Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues" 12, no. 12 (2018) Reed, Matthew et al. "Novel mass spectrometry based detection and identification of variants of rabies virus nucleoprotein in infected brain tissues" vol. 12, no. 12, 2018 Export RIS Citation Information.

:

Reed, Matthew ;

Stuchlik, Olga

December 14 2018 | PLoS Negl Trop Dis. 12(12)

:

Human rabies is an encephalitic disease transmitted by animals infected with lyssaviruses. The most common lyssavirus that causes human infection is r...
A high throughput neutralization test based on GFP expression by recombinant rabies virus

CITE Title : A high throughput neutralization test based on GFP expression by recombinant rabies virus Personal Author(s) : Burgado, Jillybeth;Greenberg, Lauren;Niezgoda, Mike;Kumar, Amrita;Olson, Victoria;Wu, Xianfu;Satheshkumar, Panayampalli Subbian; Published Date : December 14 2018 Source : PLoS Negl Trop Dis. 12(12) URL : https://stacks.cdc.gov/view/cdc/76692 Burgado, Jillybeth et al. (2018). A high throughput neutralization test based on GFP expression by recombinant rabies virus. 12(12). Burgado, Jillybeth et al. "A high throughput neutralization test based on GFP expression by recombinant rabies virus" 12, no. 12 (2018) Burgado, Jillybeth et al. "A high throughput neutralization test based on GFP expression by recombinant rabies virus" vol. 12, no. 12, 2018 Export RIS Citation Information.

:

Burgado, Jillybeth ;

Greenberg, Lauren

December 14 2018 | PLoS Negl Trop Dis. 12(12)

:

The effectiveness of rabies vaccination in both humans and animals is determined by the presence of virus neutralizing antibodies (VNAs). The Rapid Fl...
Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo, 2017

CITE Title : Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo, 2017 Personal Author(s) : Doshi, Reena H.;Guagliardo, Sarah Anne J.;Dzabatou-Babeaux, Angelie;Likouayoulou, Camille;Ndakala, Nestor;Moses, Cynthia;Olson, Victoria;McCollum, Andrea M.;Petersen, Brett W.; Published Date : Jun 2018 Source : Emerg Infect Dis. 24(6):1158-1160. URL : https://stacks.cdc.gov/view/cdc/56346 Doshi, Reena H. et al. (2018). Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo, 2017. 24(6). Doshi, Reena H. et al. "Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo, 2017" 24, no. 6 (2018) Doshi, Reena H. et al. "Strengthening of Surveillance during Monkeypox Outbreak, Republic of the Congo, 2017" vol. 24, no. 6, 2018 Export RIS Citation Information.

:

Doshi, Reena H. ;

Guagliardo, Sarah Anne J.

Jun 2018 | Emerg Infect Dis. 24(6):1158-1160.

:

Reports of 10 suspected cases of monkeypox in Likouala Department, Republic of the Congo, triggered an investigation and response in March 2017 that i...
Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel

CITE Title : Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel Personal Author(s) : Bansal, Amit;Gamal, Wael;Menon, Ipshita Jayaprakash;Olson, Victoria;Wu, Xianfu;D’Souza, Martin J.; Published Date : 12 01 2020;12-01-; Source : Eur J Pharm Sci. 155:105560 URL : https://stacks.cdc.gov/view/cdc/153556 Bansal, Amit et al. (2020). Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel. 155 Bansal, Amit et al. "Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel" 155 (2020) Bansal, Amit et al. "Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel" vol. 155, 2020 Export RIS Citation Information.

:

Bansal, Amit ;

Gamal, Wael

12 01 2020 | Eur J Pharm Sci. 155:105560

:

A painless skin delivery of vaccine for disease prevention is of great advantage in improving compliance in patients. To test this idea as a proof of ...
The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox

CITE Title : The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox Personal Author(s) : Merchlinsky, Michael;Albright, Andrew;Olson, Victoria;Schiltz, Helen;Merkeley, Tyler;Hughes, Claiborne;Petersen, Brett;Challberg, Mark; Published Date : June 07 2019 Source : Antiviral Res. 168:168-174 URL : https://stacks.cdc.gov/view/cdc/80233 Merchlinsky, Michael et al. (2019). The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox. 168 Merchlinsky, Michael et al. "The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox" 168 (2019) Merchlinsky, Michael et al. "The development and approval of tecoviromat (TPOXX®), the first antiviral against smallpox" vol. 168, 2019 Export RIS Citation Information.

:

Merchlinsky, Michael ;

Albright, Andrew

June 07 2019 | Antiviral Res. 168:168-174

:

The classification of smallpox by the U.S. Centers for Disease Control and Prevention (CDC) as a Category A Bioterrorism threat agent has resulted in ...
Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification

CITE Title : Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification Personal Author(s) : Carroll, Darin S.;Emerson, Ginny L.;Li, Yu;Sammons, Scott;Olson, Victoria;Frace, Michael;Nakazawa, Yoshinori;Czerny, Claus Peter;Tryland, Morten;Kolodziejek, Jolanta;Nowotny, Norbert;Olsen-Rasmussen, Melissa;Khristova, Marina;Govil, Dhwani;Karem, Kevin;Damon, Inger K.;Meyer, Hermann; Published Date : Aug 08 2011 Source : PLoS One. 2011; 6(8). URL : https://stacks.cdc.gov/view/cdc/4336 Carroll, Darin S. et al. (2011). Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification. 6(8). Carroll, Darin S. et al. "Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification" 6, no. 8 (2011) Carroll, Darin S. et al. "Chasing Jenner's Vaccine: Revisiting Cowpox Virus Classification" vol. 6, no. 8, 2011 Export RIS Citation Information.

:

Carroll, Darin S. ;

Emerson, Ginny L.

Aug 08 2011 | PLoS One. 2011; 6(8).

:

Cowpox virus (CPXV) is described as the source of the first vaccine used to prevent the onset and spread of an infectious disease. It is one of the ea...
Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays

CITE Title : Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays Personal Author(s) : Gates, Irina;Olson, Victoria;Smith, Scott;Patel, Nishi;Damon, Inger;Karem, Kevin; Published Date : Oct 01 2015 Source : PLoS One. 10(10). URL : https://stacks.cdc.gov/view/cdc/34883 Gates, Irina et al. (2015). Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays. 10(10). Gates, Irina et al. "Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays" 10, no. 10 (2015) Gates, Irina et al. "Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays" vol. 10, no. 10, 2015 Export RIS Citation Information.

:

Gates, Irina ;

Olson, Victoria

Oct 01 2015 | PLoS One. 10(10).

:

Currently, a number of assays measure Orthopoxvirus neutralization with serum from individuals, vaccinated against smallpox. In addition to the tradit...
Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception

CITE Title : Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception Personal Author(s) : Bansal, Amit;Gamal, Wael;Wu, Xianfu;Yang, Yong;Olson, Victoria;D’Souza, Martin J.; Published Date : 10 2019;10-2019; Source : Nanomedicine. 21:102049 URL : https://stacks.cdc.gov/view/cdc/159482 Bansal, Amit et al. (2019). Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception. 21 Bansal, Amit et al. "Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception" 21 (2019) Bansal, Amit et al. "Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception" vol. 21, 2019 Export RIS Citation Information.

:

Bansal, Amit ;

Gamal, Wael

10 2019 | Nanomedicine. 21:102049

:

Immunocontraceptive vaccination is becoming an acceptable strategy in managing animal populations. Mass vaccination of dogs is the most cost-effective...
Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox

CITE Title : Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox Personal Author(s) : Gallardo-Romero, Nadia F.;Hutson, Christina L.;Carroll, Darin;Kondas, Ashley V.;Salzer, Johanna S.;Dietz-Ostergaard, Sharon;Smith, Scott;Hudson, Paul;Olson, Victoria;Damon, Inger; Published Date : 1 2 2020;1-02-; Source : Virus Res. 275:197772 URL : https://stacks.cdc.gov/view/cdc/121738 Gallardo-Romero, Nadia F. et al. (2020). Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox. 275 Gallardo-Romero, Nadia F. et al. "Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox" 275 (2020) Gallardo-Romero, Nadia F. et al. "Use of live Variola virus to determine whether CAST/EiJ mice are a suitable surrogate animal model for human smallpox" vol. 275, 2020 Export RIS Citation Information.

:

Gallardo-Romero, Nadia F. ;

Hutson, Christina L.

1 2 2020 | Virus Res. 275:197772

:

Numerous animal models of systemic orthopoxvirus disease have been developed to evaluate therapeutics against variola virus (VARV), the causative agen...
Emergence of Monkeypox — West and Central Africa, 1970–2017

CITE Title : Emergence of Monkeypox — West and Central Africa, 1970–2017 Personal Author(s) : Durski, Kara N.;McCollum, Andrea M.;Nakazawa, Yoshinori;Petersen, Brett W.;Reynolds, Mary G.;Briand, Sylvie;Djingarey, Mamoudou Harouna;Olson, Victoria;Damon, Inger K.;Khalakdina, Asheena; Published Date : Mar 16 2018 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 67(10):306-310. DOI : http://dx.doi.org/10.15585/mmwr.mm6710a5 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Durski, Kara N. et al. (2018). Emergence of Monkeypox — West and Central Africa, 1970–2017. 67(10). http://dx.doi.org/10.15585/mmwr.mm6710a5 Durski, Kara N. et al. "Emergence of Monkeypox — West and Central Africa, 1970–2017" 67, no. 10 (2018), http://dx.doi.org/10.15585/mmwr.mm6710a5 Durski, Kara N. et al. "Emergence of Monkeypox — West and Central Africa, 1970–2017" vol. 67, no. 10, 2018, http://dx.doi.org/10.15585/mmwr.mm6710a5 Export RIS Citation Information.

:

Durski, Kara N. ;

McCollum, Andrea M.

Mar 16 2018 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

The recent apparent increase in human monkeypox cases across a wide geographic area, the potential for further spread, and the lack of reliable Survei...
Vital Signs: Trends in Human Rabies Deaths and Exposures — United States, 1938–2018

CITE Title : Vital Signs: Trends in Human Rabies Deaths and Exposures — United States, 1938–2018 Personal Author(s) : Pieracci, Emily G.;Pearson, Christine M.;Wallace, Ryan M.;Blanton, Jesse D.;Whitehouse, Erin R.;Ma, Xiaoyue;Stauffer, Kendra;Chipman, Richard B.;Olson, Victoria; Published Date : June 14 2019 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 68(23):524-528 DOI : http://dx.doi.org/10.15585/mmwr.mm6823e1 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Pieracci, Emily G. et al. (2019). Vital Signs: Trends in Human Rabies Deaths and Exposures — United States, 1938–2018. 68(23). http://dx.doi.org/10.15585/mmwr.mm6823e1 Pieracci, Emily G. et al. "Vital Signs: Trends in Human Rabies Deaths and Exposures — United States, 1938–2018" 68, no. 23 (2019), http://dx.doi.org/10.15585/mmwr.mm6823e1 Pieracci, Emily G. et al. "Vital Signs: Trends in Human Rabies Deaths and Exposures — United States, 1938–2018" vol. 68, no. 23, 2019, http://dx.doi.org/10.15585/mmwr.mm6823e1 Export RIS Citation Information.

:

Pieracci, Emily G. ;

Pearson, Christine M.

June 14 2019 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

IntroductionEach year, rabies causes approximately 59,000 deaths Worldwide, including approximately two deaths in the United States Before 1960, dogs ...